Antibe Therapeutics Inc.
ATBPF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19 | -$25 | -$25 | -$19 |
| Dep. & Amort. | $0 | $0 | $0 | $1 |
| Deferred Tax | $0 | $0 | $0 | $2 |
| Stock-Based Comp. | $3 | $6 | $4 | $3 |
| Change in WC | $0 | $3 | $20 | $2 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$16 | -$17 | -$0 | -$12 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | -$0 |
| Net Acquisitions | $0 | -$0 | $0 | $0 |
| Inv. Purchases | -$48 | -$20 | $0 | $0 |
| Inv. Sales/Matur. | $36 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$0 | -$0 | -$1 |
| Investing Cash Flow | -$12 | -$20 | -$0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$2 | -$0 |
| Stock Issued | $0 | $0 | $69 | $8 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$1 | $4 |
| Financing Cash Flow | $0 | -$0 | $66 | $12 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$28 | -$37 | $66 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35 | $72 | $6 | $6 |
| End Cash | $7 | $35 | $72 | $6 |
| Free Cash Flow | -$16 | -$17 | -$0 | -$12 |